annual cash & cash equivalents:
$76.25M-$11.96M(-13.56%)Summary
- As of today (August 25, 2025), AGIO annual cash & cash equivalents is $76.25 million, with the most recent change of -$11.96 million (-13.56%) on December 31, 2024.
- During the last 3 years, AGIO annual cash & cash equivalents has fallen by -$126.88 million (-62.46%).
- AGIO annual cash & cash equivalents is now -62.46% below its all-time high of $203.13 million, reached on December 31, 2021.
Performance
AGIO Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$938.94M+$45.56M(+5.10%)Summary
- As of today (August 25, 2025), AGIO quarterly cash & cash equivalents is $938.94 million, with the most recent change of +$45.56 million (+5.10%) on June 30, 2025.
- Over the past year, AGIO quarterly cash & cash equivalents has increased by +$369.05 million (+64.76%).
- AGIO quarterly cash & cash equivalents is now -59.80% below its all-time high of $2.34 billion, reached on March 31, 2021.
Performance
AGIO quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AGIO Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.6% | +64.8% |
| 3 y3 years | -62.5% | +14.6% |
| 5 y5 years | -5.8% | +18.8% |
AGIO Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.5% | at low | -6.5% | +64.8% |
| 5 y | 5-year | -62.5% | at low | -59.8% | +64.8% |
| alltime | all time | -62.5% | +443.4% | -59.8% | +1026.1% |
AGIO Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $938.94M(+5.1%) |
| Mar 2025 | - | $893.38M(-0.0%) |
| Dec 2024 | $76.25M(-13.6%) | $893.71M(-11.1%) |
| Sep 2024 | - | $1.00B(+76.3%) |
| Jun 2024 | - | $569.89M(-4.7%) |
| Mar 2024 | - | $597.99M(-23.0%) |
| Dec 2023 | $88.20M(-36.7%) | $776.93M(+20.0%) |
| Sep 2023 | - | $647.49M(-7.8%) |
| Jun 2023 | - | $702.57M(-5.0%) |
| Mar 2023 | - | $739.20M(-5.6%) |
| Dec 2022 | $139.26M(-31.4%) | $783.12M(+7.6%) |
| Sep 2022 | - | $727.68M(-11.2%) |
| Jun 2022 | - | $819.31M(-11.3%) |
| Mar 2022 | - | $923.53M(-9.5%) |
| Dec 2021 | $203.13M(+59.4%) | $1.02B(-19.4%) |
| Sep 2021 | - | $1.27B(-24.3%) |
| Jun 2021 | - | $1.67B(-28.4%) |
| Mar 2021 | - | $2.34B(+307.7%) |
| Dec 2020 | $127.44M(+57.5%) | $572.93M(-5.4%) |
| Sep 2020 | - | $605.54M(-23.4%) |
| Jun 2020 | - | $790.13M(+49.5%) |
| Mar 2020 | - | $528.62M(-6.4%) |
| Dec 2019 | $80.93M(+14.8%) | $564.88M(+25.0%) |
| Sep 2019 | - | $451.90M(-8.8%) |
| Jun 2019 | - | $495.39M(-5.6%) |
| Mar 2019 | - | $524.56M(-10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $70.50M(-31.4%) | $585.30M(-12.6%) |
| Sep 2018 | - | $669.89M(-6.6%) |
| Jun 2018 | - | $716.90M(-8.4%) |
| Mar 2018 | - | $782.45M(+84.6%) |
| Dec 2017 | $102.72M(-36.1%) | $423.94M(-16.5%) |
| Sep 2017 | - | $507.93M(-13.3%) |
| Jun 2017 | - | $586.04M(+22.2%) |
| Mar 2017 | - | $479.76M(-11.4%) |
| Dec 2016 | $160.75M(+124.0%) | $541.31M(-6.5%) |
| Sep 2016 | - | $579.10M(+24.4%) |
| Jun 2016 | - | $465.37M(+48.7%) |
| Mar 2016 | - | $312.89M(-1.3%) |
| Dec 2015 | $71.76M(+411.5%) | $317.00M(-10.0%) |
| Sep 2015 | - | $352.37M(-4.7%) |
| Jun 2015 | - | $369.79M(+7.3%) |
| Mar 2015 | - | $344.71M(+0.8%) |
| Dec 2014 | $14.03M(-80.4%) | $342.06M(+55.5%) |
| Sep 2014 | - | $219.97M(-7.8%) |
| Jun 2014 | - | $238.48M(+47.0%) |
| Mar 2014 | - | $162.27M(-2.7%) |
| Dec 2013 | $71.56M(-21.6%) | $166.77M(-14.5%) |
| Sep 2013 | - | $194.96M(+96.4%) |
| Jun 2013 | - | $99.28M(+19.1%) |
| Mar 2013 | - | $83.38M(-8.7%) |
| Dec 2012 | $91.30M(-22.4%) | $91.30M |
| Dec 2011 | $117.66M | - |
FAQ
- What is Agios Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Agios Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Agios Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of AGIO is $76.25M
What is the all time high annual cash & cash equivalents for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $203.13M
What is Agios Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, AGIO annual cash & cash equivalents has changed by -$11.96M (-13.56%)
What is Agios Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of AGIO is $938.94M
What is the all time high quarterly cash & cash equivalents for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $2.34B
What is Agios Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, AGIO quarterly cash & cash equivalents has changed by +$369.05M (+64.76%)